References
- Lane DP. P53 guardian of the genome. Nature 1992;358: 15—6.
- Wynford-Thomas D, Blaydes J. The influence of cell context on the selection pressure for p53 mutation in human cancer. Carcinogenesis 1998;19: 29–36.
- Ara S, Lee PS, Hansen MF, Saya H. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 1990;18:4961.
- Walker KK, Levine AJ. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 1996;93:15335–40.
- Fan R, Wu M, Miller D, Wain JC, Kelsey KT, Wiencke JK, et al. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:1037–42.
- Sifuentes Alvarez A, Reyes Romero M. Risk factors for cervico-uterine cancer associated to HPV:p53 codon 72 polymorphism in women attending hospital care. Ginecol Obstet Mex 2003;71:12–5.
- Zhang ZW, Newcomb P, Hollowood A, Feakins R, Moorghen M, Storey A, et al. Age-associated increase of codon 72 arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res 2003;9:2151–6.
- Hiyama T, Tanaka S, Kitadai Y, Ito M, Sumii M, Yoshihara M, et al. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer 2002;100:304–8.
- Shepherd T, Tolbert D, Benedetti J, Macdonald J, Stemmermann G, Wiest J, et al. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology 2000;118:1039–44.
- Anzola M, Cuevas N, Lopez-Martinez M, Saiz A, Burgos JJ, de Pancorbo MM. Frequent loss of p53 codon 72 Pro variant in hepatitis C virus-positive carriers with hepatocellular carcinoma. Cancer Lett 2003;193: 199–205.
- Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 1999;29:697–702.
- Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998;393:229–34.
- Murata M, Tagawa M, Kimura M, Kimura H, Watanabe S, Saisho H. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 1996;17:261–4.
- Buyru N, Tigli H, Dalay N. P53 codon 72 polymorphism in breast cancer. Oncol Rep 2003;10: 711–4.
- Zhang ZW, Laurence NJ, Hollowood A, Newcomb P, Moorghen M, Gupta J, et al. Prognostic value of TP53 codon 72 polymorphism in advanced gastric adenocarcinoma. Clin Cancer Res 2004;10:131–5.
- Zhang ZW, Newcomb P, Hollowood A, Feakins R, Moorghen M, Storey A, et al. Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res 2003;9:2151–6.
- Sun Y, Keshava C, Sharp DS, Weston A, McCanlies EC. DNA sequence variants ofp53: cancer and aging. Am J Hum Genet 1999;65: 1779–82.
- Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999;19:1092–100.
- Sakamuro D, Sabbatini P, White E, Prendergast GC. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 1997;15:887–98.
- Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 2001;96:16–26.
- Beckman G, Birgander R, Sjalander A, Saha N, Holmberg PA, Kivela A, et al. Is p53 polymorphism maintained by natural selection? Hum Hered 1994;44:266–70.